CI Investments Inc
IBER

CI Investments Inc’s Ibere Pharmaceuticals IBER Stock Holding History

CI Investments Inc’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,491
Closed -$44K – 1407
2022
Q2 		$44K Sell
4,491
-609
-12% -$5.97K ﹤0.01% 848
2022
Q1 		$50K Hold
5,100
– – ﹤0.01% 959
2021
Q4 		$49K Hold
5,100
– – ﹤0.01% 1008
2021
Q3 		$49K Buy
+5,100
New +$49.3K ﹤0.01% 972

Other funds holding IBER

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

CI Investments Inc's IBER Position: Q3 2022 in Review

CI Investments Inc sold out of Ibere Pharmaceuticals (IBER) in Q3 2022, closing a stake of 4,491 shares — an estimated $44K sold.

CI Investments Inc first reported a position in IBER in Q3 2021 and held it in 4 quarters. The position peaked at $50K in Q1 2022. 48 funds tracked by Wall St. Rank hold IBER as of Q3 2022.

  • CI Investments Inc reported no remaining Ibere Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CI Investments Inc sold 4,491 Ibere Pharmaceuticals shares in Q3 2022, an estimated $44K.
  • CI Investments Inc first reported a position in Ibere Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • CI Investments Inc's Ibere Pharmaceuticals position peaked at $50K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q3 2022.

Based on CI Investments Inc's 13F filing for Q3 2022, filed 14 Nov 2022.